Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults. - Silman D; Flaxman A; Datoo M; Edwards NJ; Ramos-Lopez F; Mitton C; Mair C; Bellamy D; Bowyer G; Morter R; Halbroth B; Venkatraman N; et al. (Wellcome open research, 2026)